{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:40:13Z","timestamp":1770756013807,"version":"3.50.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/100000139","name":"Environmental Protection Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000139","name":"Environmental Protection Agency","doi-asserted-by":"publisher","award":["DE-SC0014664"],"award-info":[{"award-number":["DE-SC0014664"]}],"id":[{"id":"10.13039\/100000139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Addressing human anatomical and physiological variability is a crucial component of human health risk assessment of chemicals. Experts have recommended probabilistic chemical risk assessment paradigms in which distributional adjustment factors are used to account for various sources of uncertainty and variability, including variability in the pharmacokinetic behavior of a given substance in different humans. In practice, convenient assumptions about the distribution forms of adjustment factors and human equivalent doses (HEDs) are often used. Parameters such as tissue volumes and blood flows are likewise often assumed to be lognormally or normally distributed without evaluating empirical data for consistency with these forms. In this work, we performed dosimetric extrapolations using physiologically based pharmacokinetic (PBPK) models for dichloromethane (DCM) and chloroform that incorporate uncertainty and variability to determine if the HEDs associated with such extrapolations are approximately lognormal and how they depend on the underlying distribution shapes chosen to represent model parameters. We accounted for uncertainty and variability in PBPK model parameters by randomly drawing their values from a variety of distribution types. We then performed reverse dosimetry to calculate HEDs based on animal points of departure for each set of sampled parameters. Corresponding samples of HEDs were tested to determine the impact of input parameter distributions on their central tendencies, extreme percentiles, and degree of conformance to lognormality. This work demonstrates that the measurable attributes of human variability should be considered more carefully and that generalized assumptions about parameter distribution shapes may lead to inaccurate estimates of extreme percentiles of HEDs.<\/jats:p>","DOI":"10.1093\/toxsci\/kfae067","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T04:57:20Z","timestamp":1716526640000},"page":"241-264","source":"Crossref","is-referenced-by-count":6,"title":["Evaluating the impact of anatomical and physiological variability on human equivalent doses using PBPK models"],"prefix":"10.1093","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8131-513X","authenticated-orcid":false,"given":"Celia M","family":"Schacht","sequence":"first","affiliation":[{"name":"Center for Public Health and Environmental Assessment, Office of Research and Development , U.S. Environmental Protection Agency, Durham, North Carolina 27711, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabel E","family":"Meade","sequence":"additional","affiliation":[{"name":"Applied Research Associates, Inc. Raleigh , North Carolina 27615, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3732-1433","authenticated-orcid":false,"given":"Amanda S","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Center for Public Health and Environmental Assessment, Office of Research and Development , U.S. Environmental Protection Agency, Durham, North Carolina 27711, USA"},{"name":"Oak Ridge Institute for Science and Education , Oak Ridge, Tennessee 37830, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bidya","family":"Prasad","sequence":"additional","affiliation":[{"name":"NJ DEP , Trenton, New Jersey 08608, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9699-9108","authenticated-orcid":false,"given":"Paul M","family":"Schlosser","sequence":"additional","affiliation":[{"name":"Center for Public Health and Environmental Assessment, Office of Research and Development , U.S. Environmental Protection Agency, Durham, North Carolina 27711, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2348-746X","authenticated-orcid":false,"given":"Hien T","family":"Tran","sequence":"additional","affiliation":[{"name":"Center for Research in Scientific Computation, NC State University , Raleigh, North Carolina 27607, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5570-6383","authenticated-orcid":false,"given":"Dustin F","family":"Kapraun","sequence":"additional","affiliation":[{"name":"Center for Public Health and Environmental Assessment, Office of Research and Development , U.S. Environmental Protection Agency, Durham, North Carolina 27711, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,5,25]]},"reference":[{"issue":"1\u20133","key":"2024072915002514600_kfae067-B1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0300-483X(96)03383-5","article-title":"Investigation of the impact of pharmacokinetic variability and uncertainty on risks predicted with a pharmacokinetic model for chloroform","volume":"111","author":"Allen","year":"1996","journal-title":"Toxicology"},{"issue":"1","key":"2024072915002514600_kfae067-B2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0041-008X(91)90264-F","article-title":"Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans","volume":"108","author":"Andersen","year":"1991","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"2024072915002514600_kfae067-B3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0041-008X(87)90281-X","article-title":"Physiologically based pharmacokinetics and the risk assessment process for methylene chloride","volume":"87","author":"Andersen","year":"1987","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"2024072915002514600_kfae067-B4","doi-asserted-by":"crossref","first-page":"16418","DOI":"10.1038\/s41598-021-96010-6","article-title":"Mechanisms for log normal concentration distributions in the environment","volume":"11","author":"Andersson","year":"2021","journal-title":"Sci Rep"},{"key":"2024072915002514600_kfae067-B5","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1080\/10807039.2019.1615828","article-title":"Methods for evaluating variability in human health dose\u2013response characterization","author":"Axelrad","year":"2020","journal-title":"Hum Ecol Risk Assess"},{"issue":"1","key":"2024072915002514600_kfae067-B6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/138920007779315053","article-title":"Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver","volume":"8","author":"Barter","year":"2007","journal-title":"Curr Drug Metab"},{"key":"2024072915002514600_kfae067-B7","volume-title":"Probability, statistics, and decision theory for civil engineers","author":"Benjamin","year":"1970"},{"issue":"11","key":"2024072915002514600_kfae067-B8","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/bioinformatics\/btp162","article-title":"GNU MCSim: Bayesian statistical inference for SBML-coded systems biology models","volume":"25","author":"Bois","year":"2009","journal-title":"Bioinformatics"},{"issue":"2","key":"2024072915002514600_kfae067-B9","first-page":"243","article-title":"Omnibus test contours for departures from normality based on\u221a b 1 and b 2","volume":"62","author":"Bowman","year":"1975","journal-title":"Biometrika"},{"key":"2024072915002514600_kfae067-B10","volume-title":"Statistical inference","author":"Casella","year":"2002"},{"issue":"6","key":"2024072915002514600_kfae067-B11","doi-asserted-by":"crossref","first-page":"067009","DOI":"10.1289\/EHP3368","article-title":"Beyond the RfD: broad application of a probabilistic approach to improve chemical dose-response assessments for noncancer effects: supplemental materials","volume":"126","author":"Chiu","year":"2018","journal-title":"Environ Health Perspect"},{"issue":"5","key":"2024072915002514600_kfae067-B12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/20024091064264","article-title":"Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry","volume":"32","author":"Clewell","year":"2002","journal-title":"Crit Rev Toxicol"},{"issue":"3","key":"2024072915002514600_kfae067-B13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1289\/ehp.0901250","article-title":"Issues in using human variability distributions to estimate low-dose risk","volume":"118","author":"Crump","year":"2010","journal-title":"Environ Health Perspect"},{"issue":"1","key":"2024072915002514600_kfae067-B14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.yrtph.2005.12.003","article-title":"Revised assessment of cancer risk to dichloromethane II. Application of probabilistic methods to cancer risk determinations","volume":"45","author":"David","year":"2006","journal-title":"Regul Toxicol Pharmacol"},{"issue":"2","key":"2024072915002514600_kfae067-B15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/rtph.2000.1419","article-title":"The utility of PBPK in the safety assessment of chloroform and carbon tetrachloride","volume":"32","author":"Delic","year":"2000","journal-title":"Regul Toxicol Pharmacol"},{"issue":"2","key":"2024072915002514600_kfae067-B16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/rtph.2001.1517","article-title":"Genetic polymorphisms in assessing interindividual variability in delivered dose","volume":"35","author":"Haber","year":"2002","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"2024072915002514600_kfae067-B17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1539-6924.1990.tb01013.x","article-title":"Three candidate \u201claws\u201d of uncertainty analysis","volume":"10","author":"Hattis","year":"1990","journal-title":"Risk Anal"},{"issue":"4","key":"2024072915002514600_kfae067-B18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1081\/DCT-120014793","article-title":"A straw man proposal for a quantitative definition of the RfD","volume":"25","author":"Hattis","year":"2002","journal-title":"Drug Chem Toxicol"},{"issue":"4","key":"2024072915002514600_kfae067-B19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1539-6924.1999.tb00441.x","article-title":"Human interindividual variability in parameters related to health risks","volume":"19","author":"Hattis","year":"1999","journal-title":"Risk Anal"},{"issue":"1\u20132","key":"2024072915002514600_kfae067-B20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cca.2005.11.007","article-title":"Testing experimental data for univariate normality","volume":"366","author":"Henderson","year":"2006","journal-title":"Clin Chim Acta"},{"issue":"3","key":"2024072915002514600_kfae067-B21","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1042\/bj2660675","article-title":"Testosterone-mediated regulation of mouse renal cytochrome P-450 isoenzymes","volume":"266","author":"Henderson","year":"1990","journal-title":"Biochem J"},{"key":"2024072915002514600_kfae067-B22","author":"IPCS","year":"2010"},{"key":"2024072915002514600_kfae067-B23","author":"IPCS","year":"2018"},{"key":"2024072915002514600_kfae067-B24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2307\/1403192","article-title":"A test for normality of observations and regression residuals","author":"Jarque","year":"1987","journal-title":"Int Statist Rev"},{"issue":"4","key":"2024072915002514600_kfae067-B25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1539\/joh.44.193","article-title":"Acute and subchronic inhalation toxicity of chloroform in rats and mice","volume":"44","author":"Kasai","year":"2002","journal-title":"J Occup Health"},{"issue":"6","key":"2024072915002514600_kfae067-B26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/jama.1976.03270060020020","article-title":"Mixed venous oxygen tension and hyperlactatemia: survival in severe cardiopulmonary disease","volume":"236","author":"Kasnitz","year":"1976","journal-title":"JAMA"},{"issue":"1","key":"2024072915002514600_kfae067-B27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yrtph.2005.12.007","article-title":"Revised assessment of cancer risk to dichloromethane: Part I Bayesian PBPK and dose-response modeling in mice","volume":"45","author":"Marino","year":"2006","journal-title":"Regul Toxicol Pharmacol"},{"key":"2024072915002514600_kfae067-B28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tox.2013.07.009","article-title":"PopGen: a virtual human population generator","volume":"315","author":"Mcnally","year":"2014","journal-title":"Toxicology"},{"issue":"3","key":"2024072915002514600_kfae067-B29","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/10807039891284569","article-title":"Dealing with uncertainty in risk assessment","volume":"4","author":"Murphy","year":"1998","journal-title":"Hum Ecol Risk Assess"},{"issue":"20","key":"2024072915002514600_kfae067-B30","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1080\/15287390600630146","article-title":"Enhancement of renal carcinogenicity by combined inhalation and oral exposures to chloroform in male rats","volume":"69","author":"Nagano","year":"2006","journal-title":"J Toxicol Environ Health A"},{"issue":"1","key":"2024072915002514600_kfae067-B31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0272-0590(88)90269-2","article-title":"Methylene chloride: a 2-year inhalation toxicity and oncogenicity study in rats","volume":"11","author":"Nitschke","year":"1988","journal-title":"Fundam Appl Toxicol"},{"key":"2024072915002514600_kfae067-B32","author":"NRC","year":"1983"},{"key":"2024072915002514600_kfae067-B33","author":"NRC","year":"2009"},{"issue":"3","key":"2024072915002514600_kfae067-B34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/toxsci\/13.3.533","article-title":"Variability of safe dose estimates when using complicated models of the carcinogenic process. A case study: methylene chloride","volume":"13","author":"Portier","year":"1989","journal-title":"Toxicol Sci"},{"key":"2024072915002514600_kfae067-B35","author":"R Core Team","year":"2022"},{"key":"2024072915002514600_kfae067-B36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.envint.2017.06.004","article-title":"Identifying populations sensitive to environmental chemicals by simulating toxicokinetic variability","volume":"106","author":"Ring","year":"2017","journal-title":"Environ Int"},{"issue":"8","key":"2024072915002514600_kfae067-B37","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/sim.4780100811","article-title":"Estimating departure from normality","volume":"10","author":"Royston","year":"1991","journal-title":"Stat Med"},{"issue":"2","key":"2024072915002514600_kfae067-B38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/sim.4780120209","article-title":"A pocket-calculator algorithm for the ShapiroFrancia test for non-normality: an application to medicine","volume":"12","author":"Royston","year":"1993","journal-title":"Stat Med"},{"issue":"4","key":"2024072915002514600_kfae067-B39","first-page":"547","article-title":"A remark on algorithm as 181: the W-test for normality","volume":"44","author":"Royston","year":"1995","journal-title":"J Royal Statist Soc Ser C Appl Statist"},{"issue":"2","key":"2024072915002514600_kfae067-B40","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/toxsci\/kfs320","article-title":"Application of an updated physiologically based pharmacokinetic model for chloroform to evaluate CYP2E1-mediated renal toxicity in rats and mice","volume":"131","author":"Sasso","year":"2013","journal-title":"Toxicol Sci"},{"issue":"9","key":"2024072915002514600_kfae067-B41","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0278-6915(86)90323-6","article-title":"A two-year drinking-water study of dichloromethane in rodents: I. Rats","volume":"24","author":"Serota","year":"1986","journal-title":"Food Chem Toxicol"},{"issue":"337","key":"2024072915002514600_kfae067-B42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/01621459.1972.10481232","article-title":"An approximate analysis of variance test for normality","volume":"67","author":"Shapiro","year":"1972","journal-title":"J Am Statist Assoc"},{"issue":"3\u20134","key":"2024072915002514600_kfae067-B43","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","article-title":"An analysis of variance test for normality (complete samples)","volume":"52","author":"Shapiro","year":"1965","journal-title":"Biometrika"},{"issue":"9","key":"2024072915002514600_kfae067-B44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i09","article-title":"Solving differential equations in R: package deSolve","volume":"33","author":"Soetaert","year":"2010","journal-title":"J Statist Software"},{"issue":"1","key":"2024072915002514600_kfae067-B45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0031-9384(82)90115-9","article-title":"Circadian patterning of feeding, drinking and activity during diurnal food access in rats","volume":"28","author":"Spiteri","year":"1982","journal-title":"Physiol Behav"},{"issue":"3","key":"2024072915002514600_kfae067-B46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1539-6924.1998.tb01294.x","article-title":"A probabilistic framework for the reference dose (probabilistic RfD)","volume":"18","author":"Swartout","year":"1998","journal-title":"Risk Anal"},{"issue":"1","key":"2024072915002514600_kfae067-B47","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/toxsci\/kfg152","article-title":"Biologically motivated computational modeling of chloroform cytolethality and regenerative cellular proliferation","volume":"75","author":"Tan","year":"2003","journal-title":"Toxicol Sci"},{"issue":"18","key":"2024072915002514600_kfae067-B48","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1080\/15287390600631367","article-title":"Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform","volume":"69","author":"Tan","year":"2006","journal-title":"J Toxicol Environ Health, Part A Current Issues"},{"issue":"6","key":"2024072915002514600_kfae067-B49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1522-7146(1996)11:6<305::AID-JBT6>3.0.CO;2-O","article-title":"The role of different cytochrome P450 isoforms in in vitro chloroform metabolism","volume":"11","author":"Testai","year":"1996","journal-title":"J Biochem Toxicol"},{"issue":"1","key":"2024072915002514600_kfae067-B50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/15428119691015188","article-title":"Variability in biological exposure indices using physiologically based pharmacokinetic modeling and Monte Carlo simulation","volume":"57","author":"Thomas","year":"1996","journal-title":"Am Ind Hyg Assoc J"},{"issue":"1","key":"2024072915002514600_kfae067-B51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/faat.1996.0072","article-title":"Incorporating Monte Carlo simulation into physiologically based pharmacokinetic models using advanced continuous simulation language (ACSL): a computational method","volume":"31","author":"Thomas","year":"1996","journal-title":"Fundam Appl Toxicol"},{"key":"2024072915002514600_kfae067-B52","first-page":"858","article-title":"PBPK modeling\/Monte Carlo simulation of methylene chloride kinetic changes in mice in relation to age and acute, subchronic, and chronic inhalation exposure","author":"Thomas","year":"1996"},{"key":"2024072915002514600_kfae067-B53","author":"U.S. EPA","year":"1993"},{"key":"2024072915002514600_kfae067-B54","author":"U.S. EPA","year":"2005"},{"key":"2024072915002514600_kfae067-B55","author":"U.S. EPA","year":"2006"},{"key":"2024072915002514600_kfae067-B56","author":"U.S. EPA","year":"2011"},{"key":"2024072915002514600_kfae067-B57","author":"U.S. EPA","year":"2011"},{"key":"2024072915002514600_kfae067-B58","author":"U.S. EPA","year":"2014"},{"issue":"S1","key":"2024072915002514600_kfae067-B59","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12940-022-00940-1","article-title":"Current practice and recommendations for advancing how human variability and susceptibility are considered in chemical risk assessment","volume":"21","author":"Varshavsky","year":"2023","journal-title":"Environ Health"},{"issue":"5","key":"2024072915002514600_kfae067-B60","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1539\/joh.44.283","article-title":"Carcinogenicity and chronic toxicity in rats and mice exposed to chloroform by inhalation","volume":"44","author":"Yamamoto","year":"2002","journal-title":"J Occup Health"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/toxsci\/advance-article-pdf\/doi\/10.1093\/toxsci\/kfae067\/58287830\/kfae067.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/toxsci\/article-pdf\/200\/2\/241\/58666335\/kfae067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/toxsci\/article-pdf\/200\/2\/241\/58666335\/kfae067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T23:25:32Z","timestamp":1722295532000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/200\/2\/241\/7682381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,25]]},"references-count":60,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,5,25]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfae067","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,5,25]]}}}